Hydrocortisone
Half-Life (t½) PO: 1.5h · IV: 1.5h · IM: 1.5h
Formula C21H30O5
Molecular Weight 362.46 g/mol
Aliases Cortef, Cortisone analog Pharmacological Mechanism Synthetic cortisol — same molecule as endogenous cortisol. Used as physiologic replacement in adrenal insufficiency at lower doses; pharmacologic anti-inflammatory at higher. Mineralocorticoid activity is non-trivial (unlike dexamethasone).
Half-Life & Elimination Curve (PO: 1.5h · IV: 1.5h · IM: 1.5h) 100% 50% 25% 12.5% 0% 0h 0×t½ 1.5h 1×t½ 3h 2×t½ 4.5h 3×t½ 6h 4×t½ 7.5h 5×t½ 0×t½ (0h): 100% remaining (~0.49 mg/L) 1×t½ (1.5h): 50% remaining (~0.245 mg/L) 2×t½ (3h): 25% remaining (~0.122 mg/L) 3×t½ (4.5h): 12.5% remaining (~61.2 µg/L) 4×t½ (6h): 6.3% remaining (~30.6 µg/L) 5×t½ (7.5h): 3.1% remaining (~15.3 µg/L) Plasma (PO) t½ Decay (1.5h)
0×t½ 0h 100% (0.49 mg/L) 1×t½ 1.5h 50% (0.245 mg/L) 2×t½ 3h 25% (0.122 mg/L) 3×t½ 4.5h 12.5% (61.2 µg/L) 4×t½ 6h 6.3% (30.6 µg/L) 5×t½ 7.5h 3.1% (15.3 µg/L) Dosing Guidelines Oral (PO): Typical 20 mg (Range: 10–30 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 100% · Volume of Distribution (Vd): 30 L · Absorption (ka): 3.5 h⁻¹ (t½ka ≈ 12m) [PMID 29795974 ]Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 30 L [PMID 29795974 ]Intramuscular (IM): Bioavailability (F): 100% · Volume of Distribution (Vd): 30 L · Absorption (ka): 1.58 h⁻¹ (t½ka ≈ 26m) [PMID 23672956 ]Pathways It Modulates Target Organ Systems Endocrine System Immune & Hematologic Chemical Structure & Identifiers InChIKey: JYGXADMDTFJGBT-VWUMJDOOSA-NSMILES: C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)OReferences Directory Compounds Registry Human Biology Hub